Humans are exposed to various hydrazine derivatives for therapeutic control of several diseases, and mammalian peroxidases are implicated in the oxidative metabolism of many drugs. The results presented here indicate that lacrimal-gland peroxidase is irreversibly inactivated in a mechanism-based way by phenylhydrazine, which acts as a suicidal substrate in the presence of H # O # . The pseudo-first-order kinetic constants for inactivation at pH 5n5 are K i l 18 µM, k inact l 0n25 min −" and τ &! l 2n75 min, with a second-order rate constant of 0n75i10% M −" :min −" . Approx. 27 mol of phenylhydrazine and 54 mol of H # O # are required per mol of enzyme for complete inactivation. The pHdependent inactivation kinetics indicate the involvement of an ionizable group on the enzyme with a pK a value of 5n4, protonation of which favours inactivation. SCN − , the plausible physiological electron donor of the enzyme, protects it from inactivation. Binding studies by optical difference spectroscopy indicate that phenylhydrazine interacts with the enzyme with a K D value of 60 µM, and its binding is prevented by the presence of SCN − . The enzyme is also protected by 5,5-dimethyl-1-pyrroline N-oxide, a free-radical trap, suggesting the involvement of a radical species in the inactivation. ESR studies indicate the formation of a spin-trapped phenyl radical (a N l 15n9 G and